51 | 5TVC |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(E,2S)-N-methyl-5-(5-phenoxy-3-pyridyl)pent-4-en-2-amine |
7LB |
|
0.52 |
SHOW |
52 | 2XNV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.52 |
SHOW |
53 | 5OUG |
Acetylcholine binding protein | Homo sapiens |
- |
Alpha-Lobeline |
L0B |
|
0.51 |
SHOW |
54 | 6PV8 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(3-endo)-N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine |
P1M |
|
0.51 |
SHOW |
55 | 5OAJ |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.51 |
SHOW |
56 | 6QQO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide |
JC8 |
|
0.51 |
SHOW |
57 | 4AFG |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
VARENICLINE |
QMR |
|
0.5 |
SHOW |
58 | 4AFH |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
Alpha-Lobeline |
L0B |
|
0.5 |
SHOW |
59 | 6UR8 |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.5 |
SHOW |
60 | 5FJV |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens |
Q15822 (ACHA2_HUMAN) |
EPIBATIDINE |
EPJ |
|
0.5 |
SHOW |
61 | 6SH0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone |
4P0 |
|
0.5 |
SHOW |
62 | 4WV9 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-[4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl]-8-azoniabicyclo[3.2.1]octane |
MD4 |
|
0.49 |
SHOW |
63 | 6PV7 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.48 |
SHOW |
64 | 5KXI |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.47 |
SHOW |
65 | 6USF |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.47 |
SHOW |
66 | 5AFL |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.47 |
SHOW |
67 | 6CNJ |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.47 |
SHOW |
68 | 5AFN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.47 |
SHOW |
69 | 5AFK |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.47 |
SHOW |
70 | 5AFM |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.46 |
SHOW |
71 | 5AFH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.46 |
SHOW |
72 | 3SIO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.46 |
SHOW |
73 | 5PHC |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
74 | 5PH4 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
75 | 5PIM |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
76 | 5PJF |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
77 | 5OBH |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5S)-6,6-dimethyl-5-[(6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl]-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium |
J94 |
|
0.45 |
SHOW |
78 | 5PKP |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
79 | 5PJU |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
80 | 5PL8 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
81 | 5PH8 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.45 |
SHOW |
82 | 2XNU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.45 |
SHOW |
83 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
|
0.45 |
SHOW |
84 | 5OBG |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.45 |
SHOW |
85 | 3JAD |
Glycine receptor subunit alphaZ1 | Danio rerio |
O93430 (GLRA1_DANRE) |
STRYCHNINE |
SY9 |
|
0.44 |
SHOW |
86 | 5CFB |
Glycine receptor subunit alpha-3 | Homo sapiens |
O75311 (GLRA3_HUMAN) |
STRYCHNINE |
SY9 |
|
0.43 |
SHOW |
87 | 6Y1Z |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one |
O7B |
|
0.43 |
SHOW |
88 | 3SH1 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.42 |
SHOW |
89 | 3RQW |
Gamma-aminobutyric-acid receptor subunit beta-1 | Dickeya dadantii |
E0SJQ4 (E0SJQ4_DICD3) |
ACETYLCHOLINE |
ACH |
|
0.42 |
SHOW |
90 | 6NP0 |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.41 |
SHOW |
91 | 3QKJ |
DNA (cytosine-5)-methyltransferase 3B | Homo sapiens |
Q9UBC3 (DNM3B_HUMAN) |
2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL |
BTB |
|
0.41 |
SHOW |